Flowers Lee 4
4 · HCW Biologics Inc. · Filed Dec 11, 2023
Insider Transaction Report
Form 4
Flowers Lee
SVP of Business Development
Transactions
- Exercise/Conversion
Common Stock
2023-12-08$0.14/sh+7,501$1,050→ 118,809 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-08−7,501→ 0 totalExercise: $0.14Exp: 2029-09-18→ Common Stock (7,501 underlying)
Footnotes (1)
- [F1]20% of the total shares subject to the stock option grant vested on September 16, 2020; 20% of the total shares subject to the stock option grant vested on September 16, 2021; 25% of the total shares subject to the stock option grant vested on September 16, 2022; and 35% of the total shares subject to the stock option grant vested on September 16, 2023.